Cargando…
Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes
INTRODUCTION: The diagnostic utility of in vivo amyloid β (Aβ) imaging to aid in the clinical distinction between frontotemporal dementia (FTD) and Alzheimer's disease remains unclear without data on the prevalence and severity of Aβ in pathologically confirmed FTD syndromes. METHODS: Aβ was as...
Autores principales: | Tan, Rachel H., Kril, Jillian J., Yang, Yue, Tom, Nicole, Hodges, John R., Villemagne, Victor L., Rowe, Christopher C., Leyton, Cristian E., Kwok, John B.J., Ittner, Lars M., Halliday, Glenda M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473545/ https://www.ncbi.nlm.nih.gov/pubmed/28653036 http://dx.doi.org/10.1016/j.dadm.2017.05.005 |
Ejemplares similares
-
Expanding the phenotypic associations of globular glial tau subtypes
por: Burrell, James R., et al.
Publicado: (2016) -
Amygdala subnuclei are differentially affected in the different genetic and pathological forms of frontotemporal dementia
por: Bocchetta, Martina, et al.
Publicado: (2019) -
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
por: Katzeff, Jared S., et al.
Publicado: (2022) -
Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease
por: Bright, Fiona, et al.
Publicado: (2021) -
A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia
por: Nazem, Amir, et al.
Publicado: (2018)